Primary Category:

Cancer Care Delivery, Cancer Control and Prevention Protocols

Disease Category:

Cancer Care Delivery



A Pragmatic Trial Evaluating a Colony Stimulating Factor Intervention in Standing Orders and the Effectiveness of Colony Stimulating Factor Use as Prophylaxis for Patients Receiving Chemotherapy with Intermediate Risk for Febrile Neutropenia


Limited site participation.  Open only to Billings Clinic, Bozeman Health, and Saint Alphonsus

Effective December 2nd, 2019, study S1415CD will be permanently closed to low or high risk accruals.  Intermediate risk accrual remains open for randomized sites.

Closed to accrual effective April 15, 2020.  Accrual goals met.


Eligible for screening study DCP 001